PE20070769A1 - Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncional - Google Patents
Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncionalInfo
- Publication number
- PE20070769A1 PE20070769A1 PE2006001239A PE2006001239A PE20070769A1 PE 20070769 A1 PE20070769 A1 PE 20070769A1 PE 2006001239 A PE2006001239 A PE 2006001239A PE 2006001239 A PE2006001239 A PE 2006001239A PE 20070769 A1 PE20070769 A1 PE 20070769A1
- Authority
- PE
- Peru
- Prior art keywords
- procedure
- production
- pharmaceutical preparation
- dysfunctional uterine
- oral therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Gynecology & Obstetrics (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE: A) ETINILESTRADIOL EN 0.020 mg; B) 2 mg DE 17 ALFA-CIANOMETIL-17-BETA-HIDROXIESTRA-4,9-DIEN-3-ONA (DIENOGEST). REFERIDA TAMBIEN A UN METODO DE TRATAMIENTO DE LA COMPOSICION DE DOSIS DIARIAS DE 21, 22, 23, 24, 25 Y DOSIS DIARIAS LIBRES DE INGESTA DE 7, 6, 5, 4, 3 DE MODO QUE LA CANTIDAD TOTAL DE DIAS DE CICLO ES 28. DICHA COMPOSICION ES UTIL EN LA ANTICONCEPCION ORAL
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05022318 | 2005-10-13 | ||
EP05024776A EP1774970A1 (de) | 2005-10-13 | 2005-11-14 | Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070769A1 true PE20070769A1 (es) | 2007-08-24 |
Family
ID=35229828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006001239A PE20070769A1 (es) | 2005-10-13 | 2006-10-12 | Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncional |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1774970A1 (es) |
JP (1) | JP2009511512A (es) |
AR (1) | AR056581A1 (es) |
CA (1) | CA2624380A1 (es) |
GT (1) | GT200600459A (es) |
PE (1) | PE20070769A1 (es) |
TW (1) | TW200744609A (es) |
UY (1) | UY29860A1 (es) |
WO (1) | WO2007042110A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008051140B4 (de) * | 2007-10-11 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur Herstellung eines einphasischen pharmazeutischen Präparates zur Begrenzung/Minderung des Risikos einer Tiefen-Venen-Thrombose in Einheit mit einer oralen Kontrazeption |
AT12800U1 (de) * | 2007-11-05 | 2012-11-15 | Bayer Schering Pharma Ag | Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451778B1 (en) * | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
US6251956B1 (en) | 1998-08-20 | 2001-06-26 | Ortho Pharmaceutical Corporation | Combination progestin oral contraceptive regimen |
PT1173210E (pt) * | 1999-05-04 | 2005-01-31 | Ligand Pharm Inc | Composicoes contraceptivas antiprogestativos e progestativos |
JP2002543158A (ja) * | 1999-05-04 | 2002-12-17 | ワイス | インドール誘導体およびプロゲステロン剤を含有する避妊組成物 |
PT1635843E (pt) * | 2003-06-25 | 2009-04-07 | Bayer Schering Pharma Ag | Terapia de substituição hormonal e de depressão compreendendo dienogest |
CA2771944A1 (en) * | 2003-07-16 | 2005-01-27 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
EP1535618A1 (en) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
US20050113350A1 (en) * | 2003-11-26 | 2005-05-26 | Bernd Duesterberg | Extended use combination comprising estrogens and progestins |
EP1690543A1 (de) * | 2005-02-15 | 2006-08-16 | Schering AG | Pharmazeutisches Präparat zur Kontrazeption |
-
2005
- 2005-11-14 EP EP05024776A patent/EP1774970A1/de not_active Ceased
-
2006
- 2006-09-02 CA CA002624380A patent/CA2624380A1/en not_active Abandoned
- 2006-09-02 WO PCT/EP2006/008587 patent/WO2007042110A1/de active Application Filing
- 2006-09-02 JP JP2008534885A patent/JP2009511512A/ja active Pending
- 2006-09-02 EP EP06791798A patent/EP1937273A1/de not_active Ceased
- 2006-10-12 GT GT200600459A patent/GT200600459A/es unknown
- 2006-10-12 TW TW095137565A patent/TW200744609A/zh unknown
- 2006-10-12 PE PE2006001239A patent/PE20070769A1/es not_active Application Discontinuation
- 2006-10-13 AR ARP060104488A patent/AR056581A1/es not_active Application Discontinuation
- 2006-10-13 UY UY29860A patent/UY29860A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007042110A1 (de) | 2007-04-19 |
EP1774970A1 (de) | 2007-04-18 |
EP1937273A1 (de) | 2008-07-02 |
GT200600459A (es) | 2007-05-04 |
AR056581A1 (es) | 2007-10-10 |
CA2624380A1 (en) | 2007-04-19 |
UY29860A1 (es) | 2007-05-31 |
JP2009511512A (ja) | 2009-03-19 |
TW200744609A (en) | 2007-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
CO6150188A2 (es) | Uso de teencteplasa para tratar un ictus isquemico agudo | |
AR045972A1 (es) | Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas | |
BRPI0408256A (pt) | composto, métodos de tratamento de um humano ou animal, pela limitação da replicação de células, que sofre de cáncer, que sofre de uma doença neoplástica, e que se sofre de doenças proliferativas, uso de um composto, e, processo para a preparação de um composto ou de um seu sal farmaceuticamente aceitável ou de um éster hidrolisável in vivo do mesmo | |
UA90893C2 (ru) | Пероральная дозированная форма производных гемцитабина | |
IL180612A (en) | Pharmaceuticals containing polysaccharides and their use in the preparation of immune system stimulants | |
PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
AR065816A1 (es) | Regimen anticonceptivo oral | |
PE20070769A1 (es) | Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncional | |
BR0308038A (pt) | Ambroxol para o tratamento de estados doloridos na cavidade bucal e faringe | |
CN103340952A (zh) | 一种改善女性月经不调的鼠尾草复方精油 | |
UY29861A1 (es) | Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
ATE259223T1 (de) | Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung | |
AR062894A1 (es) | Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths) | |
AR047154A1 (es) | Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol | |
CN103976882A (zh) | 一种新型根管充填剂及其使用方法 | |
JP2019514978A5 (es) | ||
BRPI0414112A (pt) | uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono | |
CA2664300A1 (en) | Agent for preventing onset of post-stroke reflex sympathetic dystrophy | |
CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
BRPI0509305A (pt) | uso de um sensibilizador insulìnico, composição farmecêutica, e , kit | |
CO6150137A2 (es) | Composicion farmaceutica que contiene bicalutamida y un metodo para su uso | |
RS50849B (sr) | Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu | |
EA202092944A1 (ru) | Применение пероральных распадающихся таблеток рилузола для лечения заболеваний |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |